Disinfectants In Interventional Practices.
Curr Pain Headache Rep
; 25(4): 21, 2021 Mar 11.
Article
in English
| MEDLINE | ID: covidwho-1126627
ABSTRACT
PURPOSE OF REVIEW This review aims to provide relevant, aggregate information about a variety of disinfectants and antiseptics, along with potential utility and limitations. While not exhaustive, this review's goal is to add to the body of literature available on this topic and give interventional providers and practitioners an additional resource to consider when performing procedures. RECENT FINDINGS:
In the current SARS-CoV2 epidemiological environment, infection control and costs associated with healthcare-associated infections (HAIs) are of paramount importance. Even before the onset of SARS-CoV2, HAIs affected nearly 2million patients a year in the USA and resulted in nearly 90,000 deaths, all of which resulted in a cost to hospitals ranging from US$28 billion to 45 billion. The onset SARS-CoV2, though not spread by an airborne route, has heightened infection control protocols in hospitals and, as such, cast a renewed focus on disinfectants and their utility across different settings and organisms. The aim of this review is to provide a comprehensive overview of disinfectants used in the inpatient setting.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cross Infection
/
Disinfectants
Type of study:
Experimental Studies
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Curr Pain Headache Rep
Journal subject:
Physiology
/
Neurology
/
Psychophysiology
Year:
2021
Document Type:
Article
Affiliation country:
S11916-021-00938-3
Similar
MEDLINE
...
LILACS
LIS